Drug Approval | July 26, 2022
Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
The product will be manufactured at Lupin's facility in Nagpur, India.
The product will be manufactured at Lupin's facility in Nagpur, India.
Better serving global partners and advancing healthcare innovation
Merck’s first microbiology application and training lab in India
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
MINYM can be safely used by patients above 9 years of age.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Subscribe To Our Newsletter & Stay Updated
